Ad26: Phase I/IIa started

Johnson & Johnson’s Janssen Vaccines & Prevention B.V. unit began a double-blind, placebo-controlled, international Phase I/IIa trial to compare intramuscular doses of Ad26.Mos4.HIV vs. Ad26.Mos.HIV a...